Chimerix, Inc. (CMRX) Financials
CMRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 194.0 million | 19.9 million |
2023-12-31 | 212.8 million | 19.7 million |
2023-09-30 | 225.3 million | 17.0 million |
2023-06-30 | 241.1 million | 17.0 million |
CMRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -17.7 million | 2.7 million |
2023-12-31 | -42.6 million | 2.3 million |
2023-09-30 | -17.9 million | 7.9 million |
2023-06-30 | -14.4 million | 3.0 million |
CMRX Net Income
No data available :(
CMRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 159.0 million | - | 1.0 million |
2023-12-31 | 182.8 million | - | 1.2 million |
2023-09-30 | 194.5 million | - | 1.3 million |
2023-06-30 | 205.8 million | - | 1.5 million |
CMRX Shares Outstanding
CMRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 27000 | 18.8 million | 5.5 million | 3000 |
2023-12-31 | 28.1 million | 15.6 million | 5.2 million | - |
2023-09-30 | 15000 | 17.4 million | 9.3 million | - |
2023-06-30 | 12000 | 16.9 million | 4.4 million | - |
CMRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | - | -3000 |
2023-12-31 | 4000 | 21.3 million |
2023-09-30 | 11000 | 15.7 million |
2023-06-30 | 26000 | 16.9 million |
CMRX
Price: $0.99
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -0.97
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 701000
Ebitda: -17.6 millionMarket Capitalization: 89.6 million